Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation: Mechanistic Implications for Desquamative Interstitial Pneumonitis.

Suzuki T, McCarthy C, Carey B, Borchers M, Beck D, Wikenheiser-Brokamp KA, Black D, Chalk C, Trapnell BC.

Am J Respir Cell Mol Biol. 2019 Jul 16. doi: 10.1165/rcmb.2018-0294OC. [Epub ahead of print]

PMID:
31310562
2.

Medical treatment for botulism.

Chalk CH, Benstead TJ, Pound JD, Keezer MR.

Cochrane Database Syst Rev. 2019 Apr 17;4:CD008123. doi: 10.1002/14651858.CD008123.pub4.

PMID:
30993666
3.

Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association.

Anderson K, Carey B, Martin A, Roark C, Chalk C, Nowell-Bostic M, Freed B, Aubrey M, Trapnell B, Fontenot A.

PLoS One. 2019 Mar 7;14(3):e0213179. doi: 10.1371/journal.pone.0213179. eCollection 2019.

4.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group.

Lancet Neurol. 2019 Mar;18(3):259-268. doi: 10.1016/S1474-4422(18)30392-2. Epub 2019 Jan 25.

PMID:
30692052
5.

Mycophenolate Mofetil-Induced Status Epilepticus.

Pellerin D, Singh K, Maniatis T, Chalk CH, Green L.

Can J Neurol Sci. 2018 Sep;45(5):585-587. doi: 10.1017/cjn.2018.326. No abstract available.

PMID:
30234475
6.

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis.

McCarthy C, Lee E, Bridges JP, Sallese A, Suzuki T, Woods JC, Bartholmai BJ, Wang T, Chalk C, Carey BC, Arumugam P, Shima K, Tarling EJ, Trapnell BC.

Nat Commun. 2018 Aug 7;9(1):3127. doi: 10.1038/s41467-018-05491-z.

7.

Prevalence and healthcare burden of pulmonary alveolar proteinosis.

McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC.

Orphanet J Rare Dis. 2018 Jul 31;13(1):129. doi: 10.1186/s13023-018-0846-y.

8.

Pulmonary Transplantation of Human Induced Pluripotent Stem Cell-derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis.

Happle C, Lachmann N, Ackermann M, Mirenska A, Göhring G, Thomay K, Mucci A, Hetzel M, Glomb T, Suzuki T, Chalk C, Glage S, Dittrich-Breiholz O, Trapnell B, Moritz T, Hansen G.

Am J Respir Crit Care Med. 2018 Aug 1;198(3):350-360. doi: 10.1164/rccm.201708-1562OC.

PMID:
29652170
9.

Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.

Gathungu G, Zhang Y, Tian X, Bonkowski E, Rowehl L, Krumsiek J, Nix B, Chalk C, Trapnell B, Zhu W, Newberry R, Denson L, Li E.

World J Gastroenterol. 2018 Feb 7;24(5):623-630. doi: 10.3748/wjg.v24.i5.623.

10.

Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Double Seronegative Myasthenia Gravis: A Systematic Review.

Bacchi S, Kramer P, Chalk C.

Can J Neurol Sci. 2018 Jan;45(1):62-67. doi: 10.1017/cjn.2017.253.

PMID:
29334041
11.

Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

Wright SS, Trauernicht A, Bonkowski E, McCall CA, Maier EA, Bezold R, Lake K, Chalk C, Trapnell BC, Kim MO, Kugathasan S, Denson LA.

J Pediatr Gastroenterol Nutr. 2018 May;66(5):767-772. doi: 10.1097/MPG.0000000000001851.

12.

Targeting cholesterol homeostasis in lung diseases.

Sallese A, Suzuki T, McCarthy C, Bridges J, Filuta A, Arumugam P, Shima K, Ma Y, Wessendarp M, Black D, Chalk C, Carey B, Trapnell BC.

Sci Rep. 2017 Aug 31;7(1):10211. doi: 10.1038/s41598-017-10879-w.

13.

A New Mutation in FIG4 Causes a Severe Form of CMT4J Involving TRPV4 in the Pathogenic Cascade.

Gentil BJ, O'Ferrall E, Chalk C, Santana LF, Durham HD, Massie R.

J Neuropathol Exp Neurol. 2017 Sep 1;76(9):789-799. doi: 10.1093/jnen/nlx062.

14.

Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.

Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH.

Cochrane Database Syst Rev. 2017 Jan 13;1:CD010369. doi: 10.1002/14651858.CD010369.pub2. Review.

15.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group.

N Engl J Med. 2016 Aug 11;375(6):511-22. doi: 10.1056/NEJMoa1602489. Erratum in: N Engl J Med. 2017 May 25;376(21):2097. [Dosage error in article text].

16.

Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.

Mah W, Sonkusare SK, Wang T, Azeddine B, Pupavac M, Carrot-Zhang J, Hong K, Majewski J, Harvey EJ, Russell L, Chalk C, Rosenblatt DS, Nelson MT, Séguin C.

J Med Genet. 2016 Oct;53(10):705-9. doi: 10.1136/jmedgenet-2016-103829. Epub 2016 Jun 21.

17.

Alexander technique and Supervised Physiotherapy Exercises in back paiN (ASPEN): a four-group randomised feasibility trial.

Little P, Stuart B, Stokes M, Nicholls C, Roberts L, Preece S, Cacciatore T, Brown S, Lewith G, Geraghty A, Yardley L, O’Reilly G, Chalk C, Sharp D, Smith P.

Southampton (UK): NIHR Journals Library; 2014 Oct.

18.

Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.

Benstead TJ, Chalk CH, Parks NE.

Cochrane Database Syst Rev. 2014 Dec 20;(12):CD010404. doi: 10.1002/14651858.CD010404.pub2. Review.

PMID:
25525951
19.

Pulmonary macrophage transplantation therapy.

Suzuki T, Arumugam P, Sakagami T, Lachmann N, Chalk C, Sallese A, Abe S, Trapnell C, Carey B, Moritz T, Malik P, Lutzko C, Wood RE, Trapnell BC.

Nature. 2014 Oct 23;514(7523):450-4. doi: 10.1038/nature13807. Epub 2014 Oct 1.

20.

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.

Jarius S, Kleffner I, Dörr JM, Sastre-Garriga J, Illes Z, Eggenberger E, Chalk C, Ringelstein M, Aktas O, Montalban X, Fechner K, Stöcker W, Ringelstein EB, Paul F, Wildemann B.

J Neuroinflammation. 2014 Mar 8;11:46. doi: 10.1186/1742-2094-11-46.

21.

Medical treatment for botulism.

Chalk CH, Benstead TJ, Keezer M.

Cochrane Database Syst Rev. 2014 Feb 20;(2):CD008123. doi: 10.1002/14651858.CD008123.pub3. Review. Update in: Cochrane Database Syst Rev. 2019 Apr 17;4:CD008123.

PMID:
24558013
22.

Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis.

Suzuki T, Mayhew C, Sallese A, Chalk C, Carey BC, Malik P, Wood RE, Trapnell BC.

Am J Respir Crit Care Med. 2014 Jan 15;189(2):183-93. doi: 10.1164/rccm.201306-1039OC.

23.

Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.

Uchida K, Nakata K, Carey B, Chalk C, Suzuki T, Sakagami T, Koch DE, Stevens C, Inoue Y, Yamada Y, Trapnell BC.

J Immunol Methods. 2014 Jan 15;402(1-2):57-70. doi: 10.1016/j.jim.2013.11.011. Epub 2013 Nov 23.

PMID:
24275678
24.

Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.

Däbritz J, Bonkowski E, Chalk C, Trapnell BC, Langhorst J, Denson LA, Foell D.

Am J Gastroenterol. 2013 Dec;108(12):1901-10. doi: 10.1038/ajg.2013.360. Epub 2013 Oct 22.

PMID:
24145675
25.

Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.

Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA.

Inflamm Bowel Dis. 2013 Sep;19(10):2146-54. doi: 10.1097/MIB.0b013e31829706e0.

26.

Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.

Jurickova I, Collins MH, Chalk C, Seese A, Bezold R, Lake K, von Allmen D, Frischer JS, Falcone RA, Trapnell BC, Denson LA.

Clin Exp Immunol. 2013 Jun;172(3):455-65. doi: 10.1111/cei.12076.

27.

'What would my classmates say?' An international study of the prediction-based method of course evaluation.

Schönrock-Adema J, Lubarsky S, Chalk C, Steinert Y, Cohen-Schotanus J.

Med Educ. 2013 May;47(5):453-62. doi: 10.1111/medu.12126.

PMID:
23574058
28.

Assessment and management of pulmonary alveolar proteinosis in a reference center.

Campo I, Mariani F, Rodi G, Paracchini E, Tsana E, Piloni D, Nobili I, Kadija Z, Corsico A, Cerveri I, Chalk C, Trapnell BC, Braschi A, Tinelli C, Luisetti M.

Orphanet J Rare Dis. 2013 Mar 13;8:40. doi: 10.1186/1750-1172-8-40.

29.

Using simulation to train junior psychiatry residents to work with agitated patients: a pilot study.

Zigman D, Young M, Chalk C.

Acad Psychiatry. 2013 Jan 1;37(1):38-41. doi: 10.1176/appi.ap.11070129.

PMID:
23338872
30.

Peer review: an effective approach to cultivating lecturing virtuosity.

McLeod P, Steinert Y, Capek R, Chalk C, Brawer J, Ruhe V, Barnett B.

Med Teach. 2013 Apr;35(4):e1046-51. doi: 10.3109/0142159X.2012.733460. Epub 2012 Oct 26.

PMID:
23102101
31.

A designer drug for amyloid polyneuropathy.

Chalk C.

Neurology. 2012 Aug 21;79(8):730-1. doi: 10.1212/WNL.0b013e3182662041. Epub 2012 Jul 25. No abstract available.

PMID:
22843277
32.

Improving the neurological exam skills of medical students.

Moore FG, Chalk C.

Can J Neurol Sci. 2012 Jan;39(1):83-6.

PMID:
22384501
33.

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.

Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, MacConaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA.

J Clin Oncol. 2012 Jan 20;30(3):316-21. doi: 10.1200/JCO.2011.36.7680. Epub 2011 Nov 7.

34.

Medical treatment for botulism.

Chalk C, Benstead TJ, Keezer M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD008123. doi: 10.1002/14651858.CD008123.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD008123.

PMID:
21412916
35.

Script concordance testing: a review of published validity evidence.

Lubarsky S, Charlin B, Cook DA, Chalk C, van der Vleuten CP.

Med Educ. 2011 Apr;45(4):329-38. doi: 10.1111/j.1365-2923.2010.03863.x. Review.

PMID:
21401680
36.

Not just numbers: qualitative research and the clinical neurosciences.

Macdonald ME, Chalk C.

Can J Neurol Sci. 2011 Mar;38(2):195-6. No abstract available.

PMID:
21320819
37.

Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations.

Suzuki T, Maranda B, Sakagami T, Catellier P, Couture CY, Carey BC, Chalk C, Trapnell BC.

Eur Respir J. 2011 Jan;37(1):201-4. doi: 10.1183/09031936.00090610. No abstract available.

38.

Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.

Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC.

Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304. doi: 10.1164/rccm.201002-0271OC. Epub 2010 Jul 9.

39.

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada.

Blackhouse G, Gaebel K, Xie F, Campbell K, Assasi N, Tarride JE, O'Reilly D, Chalk C, Levine M, Goeree R.

Cost Eff Resour Alloc. 2010 Jun 17;8:14. doi: 10.1186/1478-7547-8-14.

40.

Assessment in the context of uncertainty using the script concordance test: more meaning for scores.

Charlin B, Gagnon R, Lubarsky S, Lambert C, Meterissian S, Chalk C, Goudreau J, van der Vleuten C.

Teach Learn Med. 2010 Jul;22(3):180-6. doi: 10.1080/10401334.2010.488197.

PMID:
20563937
41.

Minocycline-induced dermatomyositis.

Geddes MR, Sinnreich M, Chalk C.

Muscle Nerve. 2010 Apr;41(4):547-9. doi: 10.1002/mus.21487.

PMID:
20120014
42.

Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.

Gaebel K, Blackhouse G, Campbell K, Robertson D, Xie F, Assasi N, Chalk C, Levine M, Goeree R.

Open Med. 2010;4(3):e154-66. Epub 2010 Aug 24.

43.

The Script Concordance Test: a new tool assessing clinical judgement in neurology.

Lubarsky S, Chalk C, Kazitani D, Gagnon R, Charlin B.

Can J Neurol Sci. 2009 May;36(3):326-31.

PMID:
19534333
44.

The essential neurologic examination: what should medical students be taught?

Moore FG, Chalk C.

Neurology. 2009 Jun 9;72(23):2020-3. doi: 10.1212/WNL.0b013e3181a92be6.

PMID:
19506224
45.

Which pedagogical principles should clinical teachers know? Teachers and education experts disagree. Disagreement on important pedagogical principles.

McLeod P, Steinert Y, Chalk C, Cruess R, Cruess S, Meterissian S, Razack S, Snell L.

Med Teach. 2009 Apr;31(4):e117-24. doi: 10.1080/01421590802335900.

PMID:
19404883
46.

Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines.

Bernstein DI, Cardin RD, Bravo FJ, Strasser JE, Farley N, Chalk C, Lay M, Fairman J.

Clin Vaccine Immunol. 2009 May;16(5):699-705. doi: 10.1128/CVI.00370-08. Epub 2009 Mar 11.

47.

Is there a higher risk of restless legs syndrome in peripheral neuropathy?

Hattan E, Chalk C, Postuma RB.

Neurology. 2009 Mar 17;72(11):955-60. doi: 10.1212/01.wnl.0000336341.72621.db. Epub 2008 Nov 26.

PMID:
19038854
48.

Making the lame walk?: transplantation for POEMS.

Chalk C.

Neurology. 2008 Nov 18;71(21):1658-9. doi: 10.1212/01.wnl.0000326574.37138.35. Epub 2008 Oct 1. No abstract available.

PMID:
18832139
49.

A pilot study designed to acquaint medical educators with basic pedagogic principles.

McLeod PJ, Brawer J, Steinert Y, Chalk C, McLeod A.

Med Teach. 2008 Feb;30(1):92-3. doi: 10.1080/01421590701770454.

PMID:
18278659
50.

The evidence for virtual reality.

Nicholson DT, Chalk C, Funnell WR, Daniel SJ.

Med Educ. 2008 Feb;42(2):224. doi: 10.1111/j.1365-2923.2007.02982.x. No abstract available.

PMID:
18230096

Supplemental Content

Support Center